Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Top Cited Papers
- 30 April 2001
- journal article
- research article
- Published by Elsevier
- Vol. 34 (4) , 593-602
- https://doi.org/10.1016/s0168-8278(01)00005-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trialsGastroenterology, 1999
- Wild-Type, but Not Mutant-Type, p53 Enhances Nuclear Accumulation of the NS3 Protein of Hepatitis C VirusBiochemical and Biophysical Research Communications, 1997
- HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy)Journal of Hepatology, 1996
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type BHepatology, 1995
- Inborn/outborn status and neonatal survival: A meta‐analysis of non‐randomized studiesStatistics in Medicine, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosisDigestive Diseases and Sciences, 1983